[The correction of secondary radiation-induced immunodeficiencies].
Review of earlier studies · 1991
- What was studied
- The available record identifies the subject in the title but gives no verified sample details.
- Main finding
- Historical review of secondary radiation-associated immune impairment. Discussion of candidate preparations is not a separate controlled trial.
Study data at a glance
- Participants or experimental model
- See original report; human, animal and laboratory components must be distinguished.
- Reported results
- Historical review of secondary radiation-associated immune impairment. Discussion of candidate preparations is not a separate controlled trial.
Study limitations and source details
Study limitations
- The abstract leaves the preparation and study methods unclear.
- Related publications may share experiments; source count is not independent-study count.
Source details
Indexed metadata and abstract checked via Europe PMC. Original full methods not reviewed.
Sources checked
Citation
Iakovlev GM, Smirnov VS, Khavinson VKh, Morozov VG.. [The correction of secondary radiation-induced immunodeficiencies]. Voenno-meditsinskii zhurnal
Related compounds
Haemalin
A historical bone-marrow polypeptide extract studied alongside the thymus preparation Thymalin. Haemalin and the later product Bonomarlot have separate formulation records.
Thymalin
A mixture of polypeptides extracted from bovine thymus. Human studies examined immune-cell measures and infection outcomes during adjunctive treatment.
Thymogen
A synthetic dipeptide, α-L-glutamyl-L-tryptophan (Glu–Trp, EW). Its alpha peptide bond and L-amino acids distinguish it from the gamma-linked immune peptides Bestim and Thymodepressin.